Literature DB >> 28418583

Lung cancer-A global perspective.

Amanda McIntyre1, Apar Kishor Ganti2.   

Abstract

Lung cancer is the leading cause of cancer deaths worldwide. While tobacco exposure is responsible for the majority of lung cancers, the incidence of lung cancer in never smokers, especially Asian women, is increasing. There is a global variation in lung cancer biology with EGFR mutations being more common in Asian patients, while Kras mutation is more common in Caucasians. This review will focus on the global variations in lung cancer and its treatment.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  EGFR mutation; global variations; lung cancer; non-smokers; resources

Mesh:

Substances:

Year:  2017        PMID: 28418583     DOI: 10.1002/jso.24532

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  26 in total

1.  HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.

Authors:  Honghong Jiang; Qiaofen Fu; Xin Song; Chunlei Ge; Ruilei Li; Zhen Li; Baozhen Zeng; Chunyan Li; Ying Wang; Yuanbo Xue; Rongcheng Luo; Weiyi Fang
Journal:  Oncol Lett       Date:  2019-09-05       Impact factor: 2.967

2.  Cytotoxic action of methylquercetins in human lung adenocarcinoma cells.

Authors:  Katrin Sak; Helen Lust; Marju Kase; Jana Jaal
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

3.  Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Authors:  Tricia L Larose; Florence Guida; Anouar Fanidi; Arnulf Langhammer; Kristian Kveem; Victoria L Stevens; Eric J Jacobs; Stephanie A Smith-Warner; Edward Giovannucci; Demetrius Albanes; Stephanie J Weinstein; Neal D Freedman; Ross Prentice; Mary Pettinger; Cynthia A Thomson; Qiuyin Cai; Jie Wu; William J Blot; Alan A Arslan; Anne Zeleniuch-Jacquotte; Loic Le Marchand; Lynne R Wilkens; Christopher A Haiman; Xuehong Zhang; Meir J Stampfer; Allison M Hodge; Graham G Giles; Gianluca Severi; Mikael Johansson; Kjell Grankvist; Renwei Wang; Jian-Min Yuan; Yu-Tang Gao; Woon-Puay Koh; Xiao-Ou Shu; Wei Zheng; Yong-Bing Xiang; Honglan Li; Qing Lan; Kala Visvanathan; Judith Hoffman Bolton; Per Magne Ueland; Øivind Midttun; Neil Caporaso; Mark Purdue; Howard D Sesso; Julie E Buring; I-Min Lee; J Michael Gaziano; Jonas Manjer; Hans Brunnström; Paul Brennan; Mattias Johansson
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

4.  Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis.

Authors:  Florian Eichhorn; Mark Kriegsmann; Laura V Klotz; Katharina Kriegsmann; Thomas Muley; Christiane Zgorzelski; Petros Christopoulos; Hauke Winter; Martin E Eichhorn
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

5.  miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2.

Authors:  Micol E Fiori; Lidia Villanova; Chiara Barbini; Maria Laura De Angelis; Ruggero De Maria
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

Review 6.  The health and social implications of household air pollution and respiratory diseases.

Authors:  Suzanne M Simkovich; Dina Goodman; Christian Roa; Mary E Crocker; Gonzalo E Gianella; Bruce J Kirenga; Robert A Wise; William Checkley
Journal:  NPJ Prim Care Respir Med       Date:  2019-04-26       Impact factor: 2.871

7.  Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer.

Authors:  Akbar Soleimani Babadi; Arda Kiani; Esmaeil Mortaz; Kimia Taghavi; Adnan Khosravi; Majid Marjani; Sharareh Seifi; Habib Emami; Atefeh Abedini
Journal:  Open Access Maced J Med Sci       Date:  2019-01-05

Review 8.  Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).

Authors:  Li-Chung Chiu; Shu-Min Lin; Yu-Lun Lo; Scott Chih-Hsi Kuo; Cheng-Ta Yang; Ping-Chih Hsu
Journal:  Vaccines (Basel)       Date:  2021-06-23

9.  Hypermethylation of normal mucosa of esophagus-specific 1 is associated with an unfavorable prognosis in patients with non-small cell lung cancer.

Authors:  Dong Sun Kim; Won Kee Lee; Jae Yong Park
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

10.  Promoter methylation of Wrap53α, an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer.

Authors:  Dong Sun Kim; Won Kee Lee; Jae Yong Park
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.